BCLI - Brainstorm Cell Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Brainstorm Cell Therapeutics's activity chart (see below) currently has 11 price targets and 23 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 50% of the time, taking 513.5 days on average.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 23-Jul-2025. First documented stock forecast 20-Jan-2015.

Best performing analysts who are covering BCLI - Brainstorm Cell Therapeutics:

Jason Kolbert Jason Mccarthy

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Oct-2024

$10

1 years 3 months 29 days ago
(23-Jul-2025)

0/4 (0%)

$8.07 (418.13%)

Hold Since 25-May-2022

$180

4 years 5 months 27 days ago
(25-May-2022)

7/7 (100%)

$134.85 (298.67%)

1027

Show more analysts

Please expand the browser size to see the chart

What is BCLI (Brainstorm Cell Therapeutics) average time for price targets to be met?

On average it took 514 days for the stock forecasts to be reached, with an average price target met ratio of 50%.

Which analyst most recently updated their price target on BCLI (Brainstorm Cell Therapeutics)?

Jason Mccarthy

Which analyst has the lowest performance score on BCLI (Brainstorm Cell Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on BCLI (Brainstorm Cell Therapeutics)?

Jason Mccarthy works at MAXIM GROUP and has 3 price targets and 3 ratings on BCLI

Which analyst is the currently most bullish on BCLI (Brainstorm Cell Therapeutics)?

Jason Kolbert with the highest potential upside of $0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?